Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

User experience and real-world implementation of a peer-integrated digital health intervention for substance use disorder.

Research square·2026
Same author

Responsiveness of the 2024-2030 ACMT Research Agenda to New Funding Priorities and Research Environment.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026
Same author

"We're All in This Together": A Mixed-Methods Study of Provider and Patient Perceptions of Emergency Care for Opioid Use Disorder.

Journal of advanced nursing·2026
Same author

mEDA: Mobile DC-EDA Circuit Validation.

... International Conference on Wearable and Implantable Body Sensor Networks. International Conference on Wearable and Implantable Body Sensor Networks·2026
Same author

What Are You Craving? Using Wearables to Distinguish Food and Drug Cravings During Treatment with Extended-Release Buprenorphine.

Proceedings of the ... Annual Hawaii International Conference on System Sciences. Annual Hawaii International Conference on System Sciences·2026
Same author

Evaluating Dry Electrodes and Bioinstrumentation for Wearable Arm ECG Acquisition.

2024 International Conference on the Challenges, Opportunities, Innovations and Applications in Electronic Textiles·2025
Same journal

Acute lung injury and progressive pulmonary fibrosis following chlorotrifluoroethylene inhalation: insights from a case.

Clinical toxicology (Philadelphia, Pa.)·2026
Same journal

Suspected serotonin toxicity following combined nefopam and tramadol use in an older adult.

Clinical toxicology (Philadelphia, Pa.)·2026
Same journal

Serum benzylpenicillin levels during treatment for amatoxin poisoning: pharmacokinetic support for OATP1B3 inhibition.

Clinical toxicology (Philadelphia, Pa.)·2026
Same journal

Unlabeled kratom alkaloids detected in products marketed as kava.

Clinical toxicology (Philadelphia, Pa.)·2026
Same journal

Contemporary survey of United States poison center treatment recommendations for sodium channel blocking drug poisoning.

Clinical toxicology (Philadelphia, Pa.)·2026
Same journal

Safety of acetylcysteine: a scoping review of iatrogenic overdose cases and their associated complications.

Clinical toxicology (Philadelphia, Pa.)·2026
See all related articles

Related Experiment Video

Updated: May 7, 2026

Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats
07:38

Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats

Published on: May 27, 2021

Difficulty creating an anticholinergic rat model with atropine

Jared Blum1, Stephanie Carreiro, Jason Hack

  • 1Department of Emergency Medicine, The Warren Alpert Medical School, Brown University , Providence, Rhode Island , USA.

Clinical Toxicology (Philadelphia, Pa.)
|September 19, 2013
PubMed
Summary

No abstract available in PubMed .

More Related Videos

A Rat Dry Eye Model with Lacrimal Gland Dysfunction Induced by Scopolamine
04:06

A Rat Dry Eye Model with Lacrimal Gland Dysfunction Induced by Scopolamine

Published on: February 9, 2024

The 6-hydroxydopamine Rat Model of Parkinson's Disease
08:10

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

Related Experiment Videos

Last Updated: May 7, 2026

Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats
07:38

Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats

Published on: May 27, 2021

A Rat Dry Eye Model with Lacrimal Gland Dysfunction Induced by Scopolamine
04:06

A Rat Dry Eye Model with Lacrimal Gland Dysfunction Induced by Scopolamine

Published on: February 9, 2024

The 6-hydroxydopamine Rat Model of Parkinson's Disease
08:10

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021